Abstract:Abstract Purpose: Telomeres play a key role in maintaining chromosome stability. Telomere length and genetic variations in maintenance genes may be associated with risk of lung cancer. A significant number of patients with non-small cell lung cancer (NSCLC) will develop recurrence after resection. To potentially identify this subgroup of patients, we hypothesized that telomere length in peripheral blood as well as genetic variations in maintenance genes would have significant predictive value for recurrence and survival after curative resection in NSCLC. Methods: This is a prospective study involving patients with early stage NSCLC who underwent resection at MD Anderson Cancer Center between 1991 and 2007. Relative telomere length (RTL) of peripheral leukocytes was measured by real-time PCR in 473 patients. 159 single nucleotide polymorphisms (SNPs) within 12 maintenance genes were genotyped in 467 patients who were treated with surgery only (N=340) or surgery and chemotherapy (N=127). The risk of recurrence was estimated as hazard ratios (HRs) and 95% confidence intervals (CIs) using a multivariable Cox proportional hazard regression model. Results: Long telomere length was associated with increased risk of recurrence (1.13 vs. 1.07, P=0.047). This increased risk was more pronounced in female (HR=2.25; 95% CI, 1.02-4.96, P=0.044) and adenocarcinoma subgroups (HR=2.19; 95% CI, 1.05-4.55, P=0.036). SNPs that were predictive of recurrence (P<0.05) were distributed into 3 different risk groups according to varying HRs when treated with surgery only or surgery plus chemo; A=should receive surgery only (HR<1 in surgery only and HR>1 in surgery+chemo); B=should receive surgery and chemo (HR>1 in surgery only and HR<1 in surgery+chemo); C=no benefit from either treatment (HR>1 in both groups). For example, patients with the 2 variant alleles of rs733396 had significantly increased risk of developing recurrence if treated with surgery alone (HR=1.85, 95% CI,1.04-3.29, P=0.036), but adding chemotherapy to patients with the same variant had a protective effect (HR=0.31, 95% CI, 0.09-1.04, P=0.057) thereby placing this variant into group B. In terms of survival, we categorized patients into favorable, intermediate and unfavorable groups based on the number of unfavorable genotypes they have. Unfavorable group (>9 unfavorable SNPs) had 3.23 fold increase in risk of overall death with median survival time (MST) of 55 months compared to favorable group (0-6 unfavorable SNPs) with MST of 136 months. Conclusions: Long telomere length is associated with increased risk of recurrence in early stage NSCLC after curative resection. Our proposed risk-prediction model using prognostic SNPs within telomere maintenance genes may be used to guide therapy and determine prognosis of patients following resection. [Supported by NCI CA 111646, CA 55769 and CA 70907] Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2249. doi:10.1158/1538-7445.AM2011-2249

Telomere Length and Recurrence Risk after Curative Resection in Women with Adenocarcinoma of the Lung: A Prospective Cohort Study.

Use of Telomere Length in Peripheral Leukocytes to Predict Risk of Recurrence in Patients with Early-Stage Non-Small Cell Lung Cancer after Curative Resection.

Abstract 2249: Use of Telomere Length and Genetic Variations in Maintenance Genes to Predict Risk of Recurrence and Survival in Patients with Early-Stage Non-Small Cell Lung Cancer

Telomere Length-Associated Genetic Variants Predict Recurrence Risk in Non-Oropharyngeal Squamous Cell Carcinoma Patients

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Prognostic Value of Leukocyte Telomere Length in Renal Cell Carcinoma Patients

Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.

Telomere in Colorectal Cancer Associated with Distant Metastases and Predicted a Poor Prognosis.

Long Telomere Length Predicts Poor Clinical Outcome in Esophageal Cancer Patients.

Leukocyte Telomere Length and Risk of Secondary Primary Tumors in Long-Term Breast Cancer Survivors

Telomere Length in White Blood Cell Dna and Lung Cancer: A Pooled Analysis of Three Prospective Cohorts

Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians.

Association of Telomere Length with Risk of Lung Cancer: A Large Prospective Cohort Study from the UK Biobank

Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients.

21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy

Genetic variations associated with telomere length predict the risk of recurrence of non‐oropharyngeal head and neck squamous cell carcinoma

Long Telomeres in Peripheral Blood Leukocytes Are Associated with an Increased Risk of Soft Tissue Sarcoma.

Longer Telomere Length in Peripheral White Blood Cells is Associated with Risk of Lung Cancer and the Rs2736100 (CLPTM1L-TERT) Polymorphism in a Prospective Cohort Study among Women in China

GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy

Abstract 1728: Genetic Variations in Epidermal Growth Factor Receptor Pathway Predict Recurrence and Response to Chemotherapy in Early Stage Non-Small Cell Lung Cancer

Time-Varying Pattern of Postoperative Recurrence Risk of Early-Stage (T1a-T2bn0m0) Non-Small Cell Lung Cancer (nsclc): Results of A Single-Center Study of 994 Chinese Patients